Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease*
The DOI matches its OpenAlex record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Tumour necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) increase endothelial surface receptors that mediate the adherence of sickle erythrocytes to the endothelium. Increased circulating levels of these cytokines have been found in patients with sickle cell disease (SCD). Monocytes are a source of both of these inflammatory mediators; we therefore determined whether circulating monocytes were activated in SCD, as defined by intracellular expression of these cytokines. Blood was also assayed for the presence of platelet-monocyte aggregates (PMAs), as platelet adherence is one possible mechanism for monocyte activation. The median percentages of monocytes expressing intracellular TNF-alpha and IL-1beta in SCD patients were 6.8 (2.8-17.3) [median (range)] and 14.1 (1.3-44.8), respectively. In African-American controls the corresponding percentages were 0.3 (0.1-0.5) and 0.4 (0.1-3.0), and in Caucasians 0.2 (0.1-0.5) and 0.8 (0.8-1.9) (P < 0.001, Kruskal-Wallis). The mean percentage (+/- SD) of PMA was 14.0 +/- 8.3 for Caucasian controls, 25.7 +/- 7.3 for African-American controls, and 45.7 +/- 21.6 for patients with SCD (P < 0.001, RM ANOVA; P < 0.05, Newman-Keuls posthoc test). We conclude that there are increased circulating PMAs and monocyte activation in patients with SCD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Prediction of Adverse Outcomes in Children with Sickle Cell Disease
Miller, S. T., Sleeper, L. A., Pegelow, C. H., Enos, L. E., Wang, W. C., Weiner, S. J., Wethers, D. L., Smith, J., & Kinney, T. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420203 · Cited by 508
Stroke in a cohort of patients with homozygous sickle cell disease
Balkaran, B., Char, G., Morris, J. S., Thomas, P. W., Serjeant, B. E., & Serjeant, G. R. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80897-2 · Cited by 419
Laboratory profile of sickle cell disease: a cross-sectional analysis
STEWARTWEST, M. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90073-v · Cited by 136
Research works printed but not linked: 44
- 1R.J. Adams (1994 ) Neurologic complications . In:Sickle Cell Disease: Basic Principles and Practice(eds S. J. Embury, R. P. Hebbel, N. Mohandas & M. H. Steinberg), pp. 599-621. Raven Press, New York.
- Belcher J.D., 2000, Blood, 96, 2451, 10.1182/blood.V96.7.2451 · DOI · Paper page
- 10.1002/(SICI)1096-8652(199604)51:4<296::AID-AJH8>3.0.CO;2-R · DOI · Paper page
- Croizat H., 1994, British Journal of Haematology, 87, 592, 10.1111/j.1365-2141.1994.tb08318.x · DOI · Paper page
- 10.1046/j.1365-2141.1996.4951036.x · DOI
- Fadlon E., 1998, Blood, 91, 266, 10.1182/blood.V91.1.266 · DOI · Paper page
- Francis R.B., 1992, Journal of the National Medical Association, 84, 611
- Francis R.B., 1991, Blood, 77, 1405, 10.1182/blood.V77.7.1405.1405 · DOI · Paper page
- 10.1016/S0735-1097(97)00510-X · DOI · Paper page
- Gawaz M., 1995, European Journal of Clinical Investigation, 25, 843, 10.1111/j.1365-2362.1995.tb01694.x · DOI · Paper page
- Graido-Gonalez E., 1997, Blood, 90, 26b
- Graido-Gonzalez E., 1998, Blood, 92, 2551, 10.1182/blood.V92.7.2551 · DOI · Paper page
- Hebbel R.P., 1997, Journal of Clinical Investigation, 99, 2561, 10.1172/JCI119442 · DOI
- Hebbel R.P., 1985, Clinical Haematology, 14, 141, 10.1016/S0308-2261(21)00466-5 · DOI
- Hebbel R.P., 1997, Journal of Laboratory and Clinical Medicine, 129, 288, 10.1016/S0022-2143(97)90176-1 · DOI
- Hendriks J., 1984, Journal of Clinical and Laboratory Immunology, 13, 129
- Hofstra T.C., 1996, Blood, 87, 4440, 10.1182/blood.V87.10.4440.bloodjournal87104440 · DOI · Paper page
- 10.1046/j.1365-2141.2000.02353.x · DOI · Paper page
- 10.1016/0022-1759(93)90158-4 · DOI · Paper page
- Kasschau M.R., 1996, Blood, 87, 771, 10.1182/blood.V87.2.771.bloodjournal872771 · DOI · Paper page
- Key N.S., 1998, Blood, 91, 4216, 10.1182/blood.V91.11.4216 · DOI · Paper page
- Kumar A., 1996, Blood, 88, 4348, 10.1182/blood.V88.11.4348.bloodjournal88114348 · DOI
- Lawson C.A., 1997, Journal of Clinical Investigation, 99, 1729, 10.1172/JCI119337 · DOI
- Mendoza E., 1991, Acta Haematologica, 85, 199, 10.1159/000204892 · DOI
- 10.1016/S0735-1097(96)00164-7 · DOI
- Natarajan M., 1996, Blood, 87, 4845, 10.1182/blood.V87.11.4845.bloodjournal87114845 · DOI
- 10.1016/S0049-3848(96)00205-8 · DOI
- 31D.R. Powars (1994 ) Natural history of disease: the first two decades . In:Sickle Cell Disease: Basic Principles and Practice(eds S. H. Embury, R. P. Hebbel, N. Mohandas & M. H. Steinberg), pp. 395-412. Raven Press, New York.
- 10.1080/09537109777113 · DOI
- Rinder C.S., 1992, Blood, 79, 1201, 10.1182/blood.V79.5.1201.1201 · DOI · Paper page
- Silverstein R.L., 1987, Journal of Clinical Investigation, 79, 867, 10.1172/JCI112896 · DOI · Paper page
- Solanki D.L., 1985, American Journal of Hematology, 20, 353, 10.1002/ajh.2830200406 · DOI
- Sultana C., 1998, Blood, 10, 3924, 10.1182/blood.V92.10.3924 · DOI · Paper page
- Swerlick R.A., 1993, Blood, 82, 1891, 10.1182/blood.V82.6.1891.1891 · DOI · Paper page
- Taylor S.C., 1989, Journal of the National Medical Association, 89, 753
- Taylor S.C., 1990, Lymphokine Research, 9, 415
- Tomer A., 1992, Blood, 80, 11
- Tomer A., 1994, Blood, 84, 412
- Vilela M.M., 1990, Journal of Tropical Pediatrics, 36, 266, 10.1093/tropej/36.5.266-a · DOI
- Vilela M.M., 1989, Brazilian Journal of Medical and Biological Research, 22, 725
- Weyrich A.S., 1996, Journal of Clinical Investigation, 97, 1525, 10.1172/JCI118575 · DOI · Paper page
- Wun T., 2001, Hematology, 5, 403, 10.1080/10245332.2000.11746536 · DOI
- 10.1046/j.1365-2141.1998.00627.x · DOI · Paper page
- 10.1016/S0022-2143(97)90005-6 · DOI · Paper page
Cited by
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
The Endothelial Biology of Sickle Cell Disease: Inflammation and a Chronic Vasculopathy
HEBBEL, R. P., OSAROGIAGBON, R., & KAUL, D. (2004) · Microcirculation · doi:10.1080/10739680490278402 · Cited by 463
Zhang, D., Xu, C., Manwani, D., & Frenette, P. S. (2016) · Blood · doi:10.1182/blood-2015-09-618538 · Cited by 413
“The first clue has emerged from the studies showing that platelet binding to monocytes leads to monocyte activation.(66) The percentage of platelet-monocyte aggregates is significantly higher in SCD patients compared with healthy controls, suggesting an increased activation level of monocytes.”
BackgroundInfluentialBarabino, G. A., Platt, M. O., & Kaul, D. K. (2010) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-070909-105339 · Cited by 311
Inflammation in sickle cell disease
Conran, N., & Belcher, J. D. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189012 · Cited by 294
Metadata
- Authors
- Wun, T., CORDOBA, M., Rangaswami, A. A., Cheung, A., & Paglieroni, T. G.
- Venue
- Clinical & Laboratory Haematology
- Publisher
- Wiley
- Published
- 2002-04
- Volume
- 24
- Issue
- 2
- Pages
- 81-88
- ISSN
- 0141-9854 (ISSN-L)
- 1365-2257
- OpenAlex
- W2052525169
- Cited by
- 130
- References
- 4
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1 (tdm, 4901 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease*. https://app.cochat.ai/papers/10.1046/j.1365-2257.2002.00433.x
- The paper
- Wun, T., CORDOBA, M., Rangaswami, A. A., Cheung, A., & Paglieroni, T. G. (2002). Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease*. Clinical & Laboratory Haematology. https://doi.org/10.1046/j.1365-2257.2002.00433.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.